The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma: An international multicenter study of 1532 patients treated with chemoimmunotherapy
Tarec Christoffer El-Galaly, Diego Villa, Thomas Yssing Michaelsen, Martin Hutchings, Nabegh George Mikhaeel, Kerry J Savage, Laurie H Sehn, Sally Barrington, Jakob W Hansen, Daniel Smith, Kirsty Rady, Karen J Mylam, Thomas S Larsen, Staffan Holmberg, Maja B Juul, Sabrina Cordua, Michael R Clausen, Kristina B Jensen, Hans E Johnsen, John F Seymour Show all
European Journal of Cancer | ELSEVIER SCI LTD | Published : 2017
This work was supported by the Karen Elise Jensen foundation (TCEG), AP Moller Maersk Foundation (TCEG) and the North Denmark Region (TCEG). JMC receives research support from the Terry Fox Research Institute, Genome Canada, Genome British Columbia, the Canadian Institutes for Health Research and the British Columbia Cancer Foundation.